Research Paper Volume 16, Issue 9 pp 8031—8043

Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing


Figure 7. Construction of the nomogram. (A) The 1-, 3-, and 5-year recurrence or mortality rates for patients TCGA-HC-A8D0 in the TCGA database were 0.0475, 0.14, and 0.203. (B) Prognostic ROC curve analysis. (C) Clinical decision benefit curve.